Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;16(8):E416-E431.
doi: 10.5489/cuaj.8054.

UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies

Andrea Kokorovic  1 , Alan I So  2 , Hosam Serag  2 , Christopher French  3 , Robert J Hamilton  4 , Jason P Izard  5 , Jasmir G Nayak  6 , Frédéric Pouliot  7 , Fred Saad  1 , Bobby Shayegan  8 , Armen Aprikian  9 , Ricardo A Rendon  10
Affiliations

UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies

Andrea Kokorovic et al. Can Urol Assoc J. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr. So has been an advisory board member for AbbVie, Amgen, Astellas, Bayer, Janssen, Ferring, and TerSera; and has participated in clinical trials supported by Astellas, Ferring, and Janssen. Dr. Izard has received a grant(s) or honoraria from AbbVie, Astellas, Bayer, Ferring, Janssen, and Sanofi; and has participated in clinical trials supported by AbbVie, Astellas, AstraZeneca, Bayer, Janssen, and Merck. Dr. Saad has been an advisory board member for and has received payment/honoraria from AbbVie, Amgen, Astellas, Bayer, Janssen, and Sanofi; and has participated in clinical trials supported by Amgen, Astellas, Bayer, Janssen, and Sanofi. Dr. Shayegan has been an advisory board member for Astellas, Bayer, and Janssen; and has received a research grant from Janssen. Dr. Aprikian has been an advisory board member for AbbVie, Astellas, and Bayer; and has received grants from AbbVie, Astellas Bayer, Sanofi, and TerSera. Dr. Rendon has been an advisory board and speakers’ bureau member for and has received honoraria from AbbVie, Amgen, Astellas, AstraZeneca, Bayer, Ferring, Jansen, and Sanofi. The remaining authors report no competing personal or financial interests related to this work. The remaining authors report no competing personal or financial interests related to this work.

Figures

Fig. 1
Fig. 1
Multidisciplinary approach to managing patients on androgen deprivation therapy (ADT). BMD: bone mineral density; BMI: body mass index; CUA: Canadian Urological Association; DXA: dual energy x-ray absorptiometry; HDL: high-density lipoprotein; LDL: low-density lipoprotein; MACE: major adverse cardiac events; PCP: primary care physician; VTE: venous thromboembolism.
See this image and copyright information in PMC

References

    1. 2020, Canadian Cancer Statistics 2020. Canadian Cancer Society;
    1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2018. Toronto, ON: Canadian Cancer Society; 2018.
    1. Center for Evidence-Based Medicine (CEBM) 2018. [Accessed Feb 13, 2021]. Available at: https://www.cebm.net.
    1. The Grading of Recommendations: Assessment, Development, and Evaluation (GRADE) working group. 2018. [Accessed Feb 12, 2021]. Available at: http://www.gradeworkinggroup.org.
    1. Pagliarulo V. Androgen Deprivation Therapy for Prostate Cancer. In: Schatten H, editor. Molecular & Diagnostic Imaging in Prostate Cancer: Clinical Applications and Treatment Strategies. Cham: Springer International Publishing; 2018. pp. 1–30. - DOI